Closing Bell: Hls Therapeutics Inc down on Wednesday (HLS)

Today, shares of Hls Therapeutics Inc opened at $3.15 and closed at $3.24. Intraday prices ranged from a low of $3.07 to a high of $3.24.

The price decreased -0.61% from the previous day's close of $3.26.

Today across North America, the TSX Composite closed -0.76% at 22639.57, the S&P 500 closed -0.16% at 5555.74, the Dow Jones Industrial Average closed -0.14% at 40358.09 and the Nasdaq Composite closed -0.06% at 17997.35.

Hls Therapeutics Inc traded under HLS on the Toronto Stock Exchange (TSX).

A total of 484,718 shares was traded during the session, with total trades of 43, with an average volume of 97,945 over 5 days.

The TSX overall saw 1,249 price advancers against 3,959 declines and 110 unchanged.

During the prior 52 weeks, HLS.TO has traded as high as $6.40 (July 26,2023) and low as $3.07 (July 24,2024). Moreover, the shares have reduced -49.38% in the last 52 weeks, while in 2024, they have slid -17.97%.

It announced a 0.05 dividend on March 15/23, with an April 27/23 ex-date and June 15/23 pay day.

Following today's trading, Hls Therapeutics Inc has a market capitalization of $103.72 million on a float of 31,815 shares outstanding. Its annual EPS is $-0.86.

Hls Therapeutics Inc is a TSX Drug Specialty & Generic company headquartered in Etobicoke, CAN.

Currently, Hls Therapeutics Inc's consensus rating is "Moderate Buy" based on 5 analysts according to Zacks. From those 5 analysts, 3 have buy ratings and 2 analysts gave hold ratings.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..